Zoledronic Acid
NDC Package 42023-151-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Zoledronic Acid is a medication used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Marketed by Par Pharmaceutical Companies, Inc., this product is identified by NDC 42023-151 and is authorized under FDA application ANDA091170.

Identification & Billing

NDC Package Code
42023-151-01
Package Description
1 VIAL, PLASTIC in 1 CARTON / 5 mL in 1 VIAL, PLASTIC
Product Code
42023-151
11-Digit Billing Format
42023015101
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Zoledronic Acid
Dosage Form
-
Usage Information
This medication is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Zoledronic acid is also used with cancer chemotherapy to treat bone problems that may occur with multiple myeloma and other types of cancer (such as breast, lung) that have spread to the bones. Zoledronic acid belongs to a class of drugs known as bisphosphonates. It lowers high blood calcium levels by reducing the amount of calcium released from your bones into your blood. It also works by slowing the breakdown of your bones by cancer to prevent bone fractures.

Regulatory & Marketing

Labeler Name
Par Pharmaceutical Companies, Inc.
FDA Application #
ANDA091170
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-04-2013
End Marketing Date
02-25-2020
Listing Expiration
02-25-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42023-151-01 identifies a specific commercial package of 1 vial, plastic in 1 carton / 5 ml in 1 vial, plastic of Zoledronic Acid, labeled by Par Pharmaceutical Companies, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Par Pharmaceutical Companies, Inc. on March 04, 2013. The current certification is valid through February 25, 2020.

What are the primary indications for this medication?

This medication is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Zoledronic acid is also used with cancer chemotherapy to treat bone problems that may occur with multiple myeloma and other types of cancer (such as breast, lung) that have spread to the bones. Zoledronic acid belongs to a class of drugs known as bisphosphonates. It lowers high blood calcium levels by reducing the amount of calcium released from your bones into your blood. It also works by slowing the breakdown of your bones by cancer to prevent bone fractures.

How is this Par Pharmaceutical Companies, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42023015101. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42023-151-01
11-Digit CMS (5-4-2)
42023-0151-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.